Global and United States Female Urinary Incontinence Treatment Device Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.

Market Analysis and Insights: Global and United States Female Urinary Incontinence Treatment Device Market

This report focuses on global and United States Female Urinary Incontinence Treatment Device market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Female Urinary Incontinence Treatment Device market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Urethral Devices accounting for % of the Female Urinary Incontinence Treatment Device global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Female Urinary Incontinence Treatment Device market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Female Urinary Incontinence Treatment Device Scope and Market Size
Female Urinary Incontinence Treatment Device market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Female Urinary Incontinence Treatment Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Female Urinary Incontinence Treatment Device market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Urethral Devices
    Internal Vaginal Devices

Segment by Application
    Hospitals
    Specialty Clinics
    Ambulatory Surgical Centers
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    BD
    Karl Storz
    Johnson and Johnson
    Coloplast
    Boston Scientific
    Teleflex
    Medtronic
    InControl Medical
    Atlantic Therapeutics Group
    Axonics Modulation Technologies
    Laborie
    Micron Medical
    American Medical Solutions

 1 Study Coverage
    1.1 Female Urinary Incontinence Treatment Device Product Introduction
    1.2 Global Female Urinary Incontinence Treatment Device Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Female Urinary Incontinence Treatment Device Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Female Urinary Incontinence Treatment Device Sales in Volume for the Year 2017-2028
    1.3 United States Female Urinary Incontinence Treatment Device Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Female Urinary Incontinence Treatment Device Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Female Urinary Incontinence Treatment Device Sales in Volume for the Year 2017-2028
    1.4 Female Urinary Incontinence Treatment Device Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Female Urinary Incontinence Treatment Device in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Female Urinary Incontinence Treatment Device Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Female Urinary Incontinence Treatment Device Market Dynamics
        1.5.1 Female Urinary Incontinence Treatment Device Industry Trends
        1.5.2 Female Urinary Incontinence Treatment Device Market Drivers
        1.5.3 Female Urinary Incontinence Treatment Device Market Challenges
        1.5.4 Female Urinary Incontinence Treatment Device Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Female Urinary Incontinence Treatment Device Market Segment by Type
        2.1.1 Urethral Devices
        2.1.2 Internal Vaginal Devices
    2.2 Global Female Urinary Incontinence Treatment Device Market Size by Type
        2.2.1 Global Female Urinary Incontinence Treatment Device Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Female Urinary Incontinence Treatment Device Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Female Urinary Incontinence Treatment Device Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Female Urinary Incontinence Treatment Device Market Size by Type
        2.3.1 United States Female Urinary Incontinence Treatment Device Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Female Urinary Incontinence Treatment Device Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Female Urinary Incontinence Treatment Device Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Female Urinary Incontinence Treatment Device Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Specialty Clinics
        3.1.3 Ambulatory Surgical Centers
        3.1.4 Others
    3.2 Global Female Urinary Incontinence Treatment Device Market Size by Application
        3.2.1 Global Female Urinary Incontinence Treatment Device Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Female Urinary Incontinence Treatment Device Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Female Urinary Incontinence Treatment Device Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Female Urinary Incontinence Treatment Device Market Size by Application
        3.3.1 United States Female Urinary Incontinence Treatment Device Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Female Urinary Incontinence Treatment Device Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Female Urinary Incontinence Treatment Device Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Female Urinary Incontinence Treatment Device Competitor Landscape by Company
    4.1 Global Female Urinary Incontinence Treatment Device Market Size by Company
        4.1.1 Top Global Female Urinary Incontinence Treatment Device Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Female Urinary Incontinence Treatment Device Revenue by Manufacturer (2017-2022)
        4.1.3 Global Female Urinary Incontinence Treatment Device Sales by Manufacturer (2017-2022)
        4.1.4 Global Female Urinary Incontinence Treatment Device Price by Manufacturer (2017-2022)
    4.2 Global Female Urinary Incontinence Treatment Device Concentration Ratio (CR)
        4.2.1 Female Urinary Incontinence Treatment Device Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Female Urinary Incontinence Treatment Device in 2021
        4.2.3 Global Female Urinary Incontinence Treatment Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Female Urinary Incontinence Treatment Device Manufacturing Base Distribution, Product Type
        4.3.1 Global Female Urinary Incontinence Treatment Device Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Female Urinary Incontinence Treatment Device Product Type
        4.3.3 Date of International Manufacturers Enter into Female Urinary Incontinence Treatment Device Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Female Urinary Incontinence Treatment Device Market Size by Company
        4.5.1 Top Female Urinary Incontinence Treatment Device Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Female Urinary Incontinence Treatment Device Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Female Urinary Incontinence Treatment Device Sales by Players (2020, 2021 & 2022)

 5 Global Female Urinary Incontinence Treatment Device Market Size by Region
    5.1 Global Female Urinary Incontinence Treatment Device Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Female Urinary Incontinence Treatment Device Market Size in Volume by Region (2017-2028)
        5.2.1 Global Female Urinary Incontinence Treatment Device Sales in Volume by Region: 2017-2022
        5.2.2 Global Female Urinary Incontinence Treatment Device Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Female Urinary Incontinence Treatment Device Market Size in Value by Region (2017-2028)
        5.3.1 Global Female Urinary Incontinence Treatment Device Sales in Value by Region: 2017-2022
        5.3.2 Global Female Urinary Incontinence Treatment Device Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Female Urinary Incontinence Treatment Device Market Size YoY Growth 2017-2028
        6.1.2 North America Female Urinary Incontinence Treatment Device Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Female Urinary Incontinence Treatment Device Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Female Urinary Incontinence Treatment Device Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Female Urinary Incontinence Treatment Device Market Size YoY Growth 2017-2028
        6.3.2 Europe Female Urinary Incontinence Treatment Device Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Female Urinary Incontinence Treatment Device Market Size YoY Growth 2017-2028
        6.4.2 Latin America Female Urinary Incontinence Treatment Device Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Female Urinary Incontinence Treatment Device Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Female Urinary Incontinence Treatment Device Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 BD
        7.1.1 BD Corporation Information
        7.1.2 BD Description and Business Overview
        7.1.3 BD Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 BD Female Urinary Incontinence Treatment Device Products Offered
        7.1.5 BD Recent Development
    7.2 Karl Storz
        7.2.1 Karl Storz Corporation Information
        7.2.2 Karl Storz Description and Business Overview
        7.2.3 Karl Storz Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Karl Storz Female Urinary Incontinence Treatment Device Products Offered
        7.2.5 Karl Storz Recent Development
    7.3 Johnson and Johnson
        7.3.1 Johnson and Johnson Corporation Information
        7.3.2 Johnson and Johnson Description and Business Overview
        7.3.3 Johnson and Johnson Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Johnson and Johnson Female Urinary Incontinence Treatment Device Products Offered
        7.3.5 Johnson and Johnson Recent Development
    7.4 Coloplast
        7.4.1 Coloplast Corporation Information
        7.4.2 Coloplast Description and Business Overview
        7.4.3 Coloplast Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Coloplast Female Urinary Incontinence Treatment Device Products Offered
        7.4.5 Coloplast Recent Development
    7.5 Boston Scientific
        7.5.1 Boston Scientific Corporation Information
        7.5.2 Boston Scientific Description and Business Overview
        7.5.3 Boston Scientific Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Boston Scientific Female Urinary Incontinence Treatment Device Products Offered
        7.5.5 Boston Scientific Recent Development
    7.6 Teleflex
        7.6.1 Teleflex Corporation Information
        7.6.2 Teleflex Description and Business Overview
        7.6.3 Teleflex Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Teleflex Female Urinary Incontinence Treatment Device Products Offered
        7.6.5 Teleflex Recent Development
    7.7 Medtronic
        7.7.1 Medtronic Corporation Information
        7.7.2 Medtronic Description and Business Overview
        7.7.3 Medtronic Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Medtronic Female Urinary Incontinence Treatment Device Products Offered
        7.7.5 Medtronic Recent Development
    7.8 InControl Medical
        7.8.1 InControl Medical Corporation Information
        7.8.2 InControl Medical Description and Business Overview
        7.8.3 InControl Medical Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 InControl Medical Female Urinary Incontinence Treatment Device Products Offered
        7.8.5 InControl Medical Recent Development
    7.9 Atlantic Therapeutics Group
        7.9.1 Atlantic Therapeutics Group Corporation Information
        7.9.2 Atlantic Therapeutics Group Description and Business Overview
        7.9.3 Atlantic Therapeutics Group Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Atlantic Therapeutics Group Female Urinary Incontinence Treatment Device Products Offered
        7.9.5 Atlantic Therapeutics Group Recent Development
    7.10 Axonics Modulation Technologies
        7.10.1 Axonics Modulation Technologies Corporation Information
        7.10.2 Axonics Modulation Technologies Description and Business Overview
        7.10.3 Axonics Modulation Technologies Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Axonics Modulation Technologies Female Urinary Incontinence Treatment Device Products Offered
        7.10.5 Axonics Modulation Technologies Recent Development
    7.11 Laborie
        7.11.1 Laborie Corporation Information
        7.11.2 Laborie Description and Business Overview
        7.11.3 Laborie Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Laborie Female Urinary Incontinence Treatment Device Products Offered
        7.11.5 Laborie Recent Development
    7.12 Micron Medical
        7.12.1 Micron Medical Corporation Information
        7.12.2 Micron Medical Description and Business Overview
        7.12.3 Micron Medical Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Micron Medical Products Offered
        7.12.5 Micron Medical Recent Development
    7.13 American Medical Solutions
        7.13.1 American Medical Solutions Corporation Information
        7.13.2 American Medical Solutions Description and Business Overview
        7.13.3 American Medical Solutions Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 American Medical Solutions Products Offered
        7.13.5 American Medical Solutions Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Female Urinary Incontinence Treatment Device Industry Chain Analysis
    8.2 Female Urinary Incontinence Treatment Device Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Female Urinary Incontinence Treatment Device Distributors
    8.3 Female Urinary Incontinence Treatment Device Production Mode & Process
    8.4 Female Urinary Incontinence Treatment Device Sales and Marketing
        8.4.1 Female Urinary Incontinence Treatment Device Sales Channels
        8.4.2 Female Urinary Incontinence Treatment Device Distributors
    8.5 Female Urinary Incontinence Treatment Device Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Female Urinary Incontinence Treatment Device CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Female Urinary Incontinence Treatment Device Market Trends
    Table 3. Female Urinary Incontinence Treatment Device Market Drivers
    Table 4. Female Urinary Incontinence Treatment Device Market Challenges
    Table 5. Female Urinary Incontinence Treatment Device Market Restraints
    Table 6. Global Female Urinary Incontinence Treatment Device Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Female Urinary Incontinence Treatment Device Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Female Urinary Incontinence Treatment Device Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Female Urinary Incontinence Treatment Device Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Female Urinary Incontinence Treatment Device Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Female Urinary Incontinence Treatment Device Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Female Urinary Incontinence Treatment Device Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Female Urinary Incontinence Treatment Device Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Female Urinary Incontinence Treatment Device Sales Share by Manufacturer, 2017-2022
    Table 15. Global Female Urinary Incontinence Treatment Device Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Female Urinary Incontinence Treatment Device Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Female Urinary Incontinence Treatment Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Urinary Incontinence Treatment Device as of 2021)
    Table 18. Top Players of Female Urinary Incontinence Treatment Device in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Female Urinary Incontinence Treatment Device Product Type
    Table 20. Date of International Manufacturers Enter into Female Urinary Incontinence Treatment Device Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Female Urinary Incontinence Treatment Device Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Female Urinary Incontinence Treatment Device Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Female Urinary Incontinence Treatment Device Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Female Urinary Incontinence Treatment Device Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Female Urinary Incontinence Treatment Device Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Female Urinary Incontinence Treatment Device Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Female Urinary Incontinence Treatment Device Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Female Urinary Incontinence Treatment Device Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Female Urinary Incontinence Treatment Device Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Female Urinary Incontinence Treatment Device Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Female Urinary Incontinence Treatment Device Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Female Urinary Incontinence Treatment Device Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Female Urinary Incontinence Treatment Device Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Female Urinary Incontinence Treatment Device Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Female Urinary Incontinence Treatment Device Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Female Urinary Incontinence Treatment Device Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Female Urinary Incontinence Treatment Device Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Female Urinary Incontinence Treatment Device Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Female Urinary Incontinence Treatment Device Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Female Urinary Incontinence Treatment Device Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. BD Corporation Information
    Table 43. BD Description and Business Overview
    Table 44. BD Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. BD Female Urinary Incontinence Treatment Device Product
    Table 46. BD Recent Development
    Table 47. Karl Storz Corporation Information
    Table 48. Karl Storz Description and Business Overview
    Table 49. Karl Storz Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Karl Storz Product
    Table 51. Karl Storz Recent Development
    Table 52. Johnson and Johnson Corporation Information
    Table 53. Johnson and Johnson Description and Business Overview
    Table 54. Johnson and Johnson Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Johnson and Johnson Product
    Table 56. Johnson and Johnson Recent Development
    Table 57. Coloplast Corporation Information
    Table 58. Coloplast Description and Business Overview
    Table 59. Coloplast Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Coloplast Product
    Table 61. Coloplast Recent Development
    Table 62. Boston Scientific Corporation Information
    Table 63. Boston Scientific Description and Business Overview
    Table 64. Boston Scientific Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Boston Scientific Product
    Table 66. Boston Scientific Recent Development
    Table 67. Teleflex Corporation Information
    Table 68. Teleflex Description and Business Overview
    Table 69. Teleflex Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Teleflex Product
    Table 71. Teleflex Recent Development
    Table 72. Medtronic Corporation Information
    Table 73. Medtronic Description and Business Overview
    Table 74. Medtronic Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Medtronic Product
    Table 76. Medtronic Recent Development
    Table 77. InControl Medical Corporation Information
    Table 78. InControl Medical Description and Business Overview
    Table 79. InControl Medical Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. InControl Medical Product
    Table 81. InControl Medical Recent Development
    Table 82. Atlantic Therapeutics Group Corporation Information
    Table 83. Atlantic Therapeutics Group Description and Business Overview
    Table 84. Atlantic Therapeutics Group Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Atlantic Therapeutics Group Product
    Table 86. Atlantic Therapeutics Group Recent Development
    Table 87. Axonics Modulation Technologies Corporation Information
    Table 88. Axonics Modulation Technologies Description and Business Overview
    Table 89. Axonics Modulation Technologies Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Axonics Modulation Technologies Product
    Table 91. Axonics Modulation Technologies Recent Development
    Table 92. Laborie Corporation Information
    Table 93. Laborie Description and Business Overview
    Table 94. Laborie Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Laborie Product
    Table 96. Laborie Recent Development
    Table 97. Micron Medical Corporation Information
    Table 98. Micron Medical Description and Business Overview
    Table 99. Micron Medical Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Micron Medical Product
    Table 101. Micron Medical Recent Development
    Table 102. American Medical Solutions Corporation Information
    Table 103. American Medical Solutions Description and Business Overview
    Table 104. American Medical Solutions Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. American Medical Solutions Product
    Table 106. American Medical Solutions Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Female Urinary Incontinence Treatment Device Customers List
    Table 110. Female Urinary Incontinence Treatment Device Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Female Urinary Incontinence Treatment Device Product Picture
    Figure 2. Global Female Urinary Incontinence Treatment Device Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Female Urinary Incontinence Treatment Device Market Size 2017-2028 (US$ Million)
    Figure 4. Global Female Urinary Incontinence Treatment Device Sales 2017-2028 (K Units)
    Figure 5. United States Female Urinary Incontinence Treatment Device Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Female Urinary Incontinence Treatment Device Market Size 2017-2028 (US$ Million)
    Figure 7. United States Female Urinary Incontinence Treatment Device Sales 2017-2028 (K Units)
    Figure 8. United States Female Urinary Incontinence Treatment Device Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Female Urinary Incontinence Treatment Device Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Female Urinary Incontinence Treatment Device Report Years Considered
    Figure 11. Product Picture of Urethral Devices
    Figure 12. Product Picture of Internal Vaginal Devices
    Figure 13. Global Female Urinary Incontinence Treatment Device Market Share by Type in 2022 & 2028
    Figure 14. Global Female Urinary Incontinence Treatment Device Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Female Urinary Incontinence Treatment Device Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Female Urinary Incontinence Treatment Device Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Female Urinary Incontinence Treatment Device Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Female Urinary Incontinence Treatment Device Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Female Urinary Incontinence Treatment Device Market Share by Type in 2022 & 2028
    Figure 20. United States Female Urinary Incontinence Treatment Device Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Female Urinary Incontinence Treatment Device Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Female Urinary Incontinence Treatment Device Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Female Urinary Incontinence Treatment Device Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Female Urinary Incontinence Treatment Device Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Hospitals
    Figure 26. Product Picture of Specialty Clinics
    Figure 27. Product Picture of Ambulatory Surgical Centers
    Figure 28. Product Picture of Others
    Figure 29. Global Female Urinary Incontinence Treatment Device Market Share by Application in 2022 & 2028
    Figure 30. Global Female Urinary Incontinence Treatment Device Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Female Urinary Incontinence Treatment Device Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Female Urinary Incontinence Treatment Device Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Female Urinary Incontinence Treatment Device Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Female Urinary Incontinence Treatment Device Price by Application (2017-2028) & (US$/Unit)
    Figure 35. United States Female Urinary Incontinence Treatment Device Market Share by Application in 2022 & 2028
    Figure 36. United States Female Urinary Incontinence Treatment Device Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Female Urinary Incontinence Treatment Device Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Female Urinary Incontinence Treatment Device Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Female Urinary Incontinence Treatment Device Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Female Urinary Incontinence Treatment Device Price by Application (2017-2028) & (US$/Unit)
    Figure 41. North America Female Urinary Incontinence Treatment Device Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Female Urinary Incontinence Treatment Device Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. United States Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Female Urinary Incontinence Treatment Device Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Female Urinary Incontinence Treatment Device Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Female Urinary Incontinence Treatment Device Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Female Urinary Incontinence Treatment Device Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. China Taiwan Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Female Urinary Incontinence Treatment Device Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Female Urinary Incontinence Treatment Device Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Colombia Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Female Urinary Incontinence Treatment Device Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Female Urinary Incontinence Treatment Device Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Female Urinary Incontinence Treatment Device Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Female Urinary Incontinence Treatment Device Value Chain
    Figure 75. Female Urinary Incontinence Treatment Device Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed

Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.

Market Analysis and Insights: Global and United States Female Urinary Incontinence Treatment Device Market

This report focuses on global and United States Female Urinary Incontinence Treatment Device market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Female Urinary Incontinence Treatment Device market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Urethral Devices accounting for % of the Female Urinary Incontinence Treatment Device global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Female Urinary Incontinence Treatment Device market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Female Urinary Incontinence Treatment Device Scope and Market Size
Female Urinary Incontinence Treatment Device market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Female Urinary Incontinence Treatment Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Female Urinary Incontinence Treatment Device market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Urethral Devices
    Internal Vaginal Devices

Segment by Application
    Hospitals
    Specialty Clinics
    Ambulatory Surgical Centers
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    BD
    Karl Storz
    Johnson and Johnson
    Coloplast
    Boston Scientific
    Teleflex
    Medtronic
    InControl Medical
    Atlantic Therapeutics Group
    Axonics Modulation Technologies
    Laborie
    Micron Medical
    American Medical Solutions